What labs should be drawn in a 66-year-old man with a history of hemolytic anemia, diverticulitis, and coronary artery disease (CAD) who presents with a feeling of being unwell and tachycardia with mild skipped beats?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Tests for a 66-Year-Old Man with Hemolytic Anemia, Diverticulitis, and CAD Presenting with Feeling "Off" and Tachycardia

A comprehensive laboratory panel including complete blood count, cardiac biomarkers, electrolytes, renal function, and hemolysis markers should be ordered immediately for this patient with multiple risk factors presenting with tachycardia and feeling unwell.

Initial Laboratory Evaluation

Cardiac and Vital Assessment

  • High-sensitivity troponin (preferably serial measurements) to rule out acute myocardial injury 1
  • 12-lead ECG (immediately, especially during symptoms) 1
  • Basic metabolic panel (electrolytes, renal function) 1
  • BNP or NT-proBNP to assess for heart failure

Hemolysis Evaluation

  • Complete blood count with differential and reticulocyte count 1, 2
  • Peripheral blood smear (to assess for schistocytes and abnormal RBC morphology) 3, 4
  • Hemolysis panel:
    • Lactate dehydrogenase (LDH)
    • Haptoglobin
    • Unconjugated bilirubin 3, 4
  • Direct antiglobulin test (Coombs test) to differentiate immune from non-immune hemolysis 4

Additional Tests Based on Clinical Presentation

  • Creatinine with estimation of renal function (GFR) 1
  • Liver function tests 1
  • Thyroid function tests (TSH, free T4) 1
  • Glycemic status (HbA1c and/or fasting plasma glucose) 1
  • Iron studies (serum iron, ferritin, TIBC, transferrin saturation) 1, 5
  • Inflammatory markers (hs-CRP and/or fibrinogen) 1

Rationale and Interpretation

Cardiac Considerations

The patient's history of CAD and current tachycardia with "skipped beats" raises concern for an acute coronary syndrome or arrhythmia. The 2024 ESC guidelines recommend immediate troponin measurement using high-sensitivity assays to rule out acute myocardial injury 1. Serial measurements may be necessary as a single normal value doesn't exclude ACS.

Hemolytic Anemia Evaluation

For a patient with known hemolytic anemia who is feeling unwell, it's critical to assess the current status of hemolysis. Reticulocytosis, increased LDH and unconjugated bilirubin, and decreased haptoglobin are the hallmarks of ongoing hemolysis 3, 4. The peripheral smear can provide clues to the specific type of hemolytic anemia and whether there's an acute exacerbation.

Renal Function

Renal dysfunction increases the likelihood of CAD and negatively impacts prognosis 1. Additionally, patients with CKD are at high risk for further ischemic events 1. Creatinine clearance is essential for medication dosing and risk stratification.

Special Considerations

  • Anemia and CAD: Anemia is associated with worse prognosis across the spectrum of CAD. The probability of cardiovascular death, MI, or recurrent ischemia increases as hemoglobin falls below 11 g/dL 1.

  • Hemolytic Crisis: In a patient with known hemolytic anemia, an acute hemolytic crisis can present with tachycardia and feeling unwell. The hemolysis panel will help determine if there's an acute exacerbation.

  • Arrhythmia Evaluation: The "skipped beats" may indicate premature atrial or ventricular contractions, which can be associated with electrolyte abnormalities, anemia, or cardiac ischemia.

  • Pitfall to Avoid: Don't attribute all symptoms to hemolytic anemia without ruling out acute cardiac pathology in a patient with CAD history. The feeling of being "off" with tachycardia could represent an acute coronary syndrome requiring immediate intervention.

By systematically evaluating cardiac, hematologic, and metabolic parameters, you can determine whether the patient's presentation represents an exacerbation of hemolytic anemia, an acute cardiac event, or another process related to his multiple comorbidities.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Evaluation and Management of Abnormal Complete Blood Count (CBC) Results

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hemolytic anemia.

American family physician, 2004

Research

Hemolytic Anemia: Evaluation and Differential Diagnosis.

American family physician, 2018

Research

How to approach chronic anemia.

Hematology. American Society of Hematology. Education Program, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.